Delivery Order SPE2DB25D3007-SPE2DB26FWQUE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,267.45 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of April 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 10 mg/0.5 ml pen (0.5ml) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this diabetes medication under a larger contract vehicle. This award is a child delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,897.78 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens (a diabetes medication) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a relatively small transaction within...
- The Defense Logistics Agency awarded a $6,670.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.5 milliliter pens of Mounjaro 2.5 milligrams, a diabetes medication. The contract was competitively awarded with no set-aside designation and is scheduled for completion by September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $7,131.67 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $2,176.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, and represents a non-competitive delivery order under the company's existing contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,631.78 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,635.27 for Mounjaro 5 mg/0.5 mL pen (0.5 mL), a diabetes medication, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,737.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive delivery order executed under an existing contract vehicle. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DB25D3007Indefinite Delivery Contract
- SPE2DB25D3007-SPE2DB26FWQUEDelivery Order
The Defense Logistics Agency awarded a $1,632.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5 ml), a diabetes medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by October 27, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance, aligning with the company's role as a primary pharmaceutical distributor for federal medical procurement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The Defense Logistics Agency is pursuing a strategic approach for pharmaceutical procurement through the Pharmaceutical Prime Vendor Global Program Generation V contracts, which will involve multiple awards across separate regions, positioning AmerisourceBergen alongside other contractors to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/24/25 |